Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.